Skip to main content
Year archive

Sinco Pharmaceuticals Holdings Limited — 2019 filings

All 111 regulatory filings released by Sinco Pharmaceuticals Holdings Limited (6833) in 2019, sourced directly from the official regulator.

111 Filings
2019 Period
2019 filings (111)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT - "TICAGRELOR TABLET" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-12-20 English
VOLUNTARY ANNOUNCEMENT - "BORTEZOMIB FOR INJECTION" OBTAINS APPROVAL OF DRUG SUPPLEMENTARY APPLICATION
Regulatory Filings
2019-12-16 English
VOLUNTARY ANNOUNCEMENT- "ARGATROBAN INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-12-12 English
VOLUNTARY ANNOUNCEMENT - "BENDAMUSTINE HYDROCHLORIDE FOR INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-12-11 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings
2019-12-10 English
MEMORANDUM OF UNDERSTANDING IN RELATION TO THE POSSIBLE ACQUISITION OF ZHONGSHAN SINOBIOWAY
M&A Activity
2019-12-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2019
Regulatory Filings
2019-12-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2019
Major Shareholding Notification
2019-12-02 English
VOLUNTARY ANNOUNCEMENT - "ESOMEPRAZOLE SODIUM FOR INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-11-27 English
THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER, 2019
Interim / Quarterly Report 9M 2019
2019-11-26 English
VOLUNTARY ANNOUNCEMENT - "LENALIDOMIDE CAPSULES" OBTAINS APPROVAL OF DRUG SUPPLEMENTARY APPLICATION
Regulatory Filings
2019-11-21 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2019
Share Issue/Capital Change
2019-11-06 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2019-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2019
Share Issue/Capital Change
2019-11-01 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "LENALIDOMIDE CAPSULES"
Regulatory Filings
2019-10-31 English
VOLUNTARY ANNOUNCEMENT - "FOSAPREPITANT DIMEGLUMINE FOR INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-10-30 English
CHANGE OF COMPANY SECRETARY CHANGE OF AUTHORISED REPRESENTATIVE CHANGE OF PROCESS AGENT AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Board/Management Information
2019-10-25 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2019-10-23 English
APPOINTMENT OF EXECUTIVE DIRECTOR
Board/Management Information
2019-10-23 English
TRANSFER OF SHARES IN THE COMPANY
Major Shareholding Notification
2019-10-22 English
VOLUNTARY ANNOUNCEMENT - "TICAGRELOR TABLET" OBTAINS ANDA APPROVAL FROM FDA
Regulatory Filings
2019-10-14 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings
2019-10-10 English
VOLUNTARY ANNOUNCEMENT - "TOFACITINIB CITRATE TABLET" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-10-09 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2019
Share Issue/Capital Change
2019-10-08 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2019
Share Issue/Capital Change
2019-10-03 English
Interim Report 2019
Interim / Quarterly Report H1 2019
2019-09-27 English
VOLUNTARY ANNOUNCEMENT STRATEGIC COOPERATION WITH SINOBIOWAY
Capital/Financing Update
2019-09-20 English
2019 INTERIM REPORT
Interim / Quarterly Report H1 2019
2019-09-17 English
VOLUNTARY ANNOUNCEMENT - "ANLOTINIB HYDROCHLORIDE CAPSULES" OBTAINS APPROVAL FOR THIRD INDICATION
Regulatory Filings
2019-09-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2019
Regulatory Filings
2019-09-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2019
Share Issue/Capital Change
2019-09-02 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2019
Interim / Quarterly Report H1 2019
2019-08-30 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE, 2019
Interim / Quarterly Report H1 2019
2019-08-28 English
DATE OF BOARD MEETING
Report Publication Announcement
2019-08-20 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2019
Regulatory Filings
2019-08-06 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2019-08-02 English
VOLUNTARY ANNOUNCEMENT - "IMATINIB MESYLATE CAPSULES" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2019-08-01 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2019-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2019
Share Issue/Capital Change
2019-08-01 English
POSITIVE PROFIT ALERT OF THE RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2019
Earnings Release H1 2019
2019-07-31 English
2018 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information
2019-07-26 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 18 JULY 2019
Declaration of Voting Results & Voting Rights Announcements
2019-07-18 English
VOLUNTARY ANNOUNCEMENT - "METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2019-07-18 English
VOLUNTARY ANNOUNCEMENT - "ABIRATERONE ACETATE TABLET" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-07-17 English
VOLUNTARY ANNOUNCEMENT - "MOXIFLOXACIN HYDROCHLORIDE INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-07-16 English
VOLUNTARY ANNOUNCEMENT - "ANLOTINIB HYDROCHLORIDE CAPSULES" OBTAINS APPROVAL FOR NEW INDICATION
Regulatory Filings
2019-07-05 English
VOLUNTARY ANNOUNCEMENT - "TICAGRELOR TABLET" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-07-04 English
VOLUNTARY ANNOUNCEMENT - "TADALAFIL TABLET" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-07-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2019
Share Issue/Capital Change
2019-07-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2019
Share Issue/Capital Change
2019-07-02 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2019-06-27 English
FORM OF PROXY FOR USE AT EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2019-06-27 English
PROPOSED CHANGE OF AUDITORS AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2019-06-27 English
CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2019-06-24 English
PROPOSED CHANGE OF AUDITORS
Audit Report / Information FY 2019
2019-06-17 English
VOLUNTARY ANNOUNCEMENT - FORMATION OF JOINT VENTURE
Capital/Financing Update
2019-06-17 English
VOLUNTARY ANNOUNCEMENT - "CASPOFUNGIN ACETATE FOR INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-06-17 English
VOLUNTARY ANNOUNCEMENT - "GADOXETATE DISODIUM INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-06-12 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 5 JUNE 2019
Declaration of Voting Results & Voting Rights Announcements
2019-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2019
Capital/Financing Update
2019-06-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2019
Share Issue/Capital Change
2019-06-03 English
VOLUNTARY ANNOUNCEMENT "PALONOSETRON HYDROCHLORIDE INJECTION" OBTAINS APPORVALS OF DRUG SUPPLEMENTARY APPLICATION
Regulatory Filings
2019-05-28 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 24 MAY 2019
Declaration of Voting Results & Voting Rights Announcements
2019-05-24 English
VOLUNTARY ANNOUNCEMENT - "TENOFOVIR TABLET" OBTAINS EUROPEAN UNION MARKETING AUTHORIZATION
Regulatory Filings
2019-05-23 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings
2019-05-22 English
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH, 2019
Interim / Quarterly Report Q1 2019
2019-05-21 English
VOLUNTARY ANNOUNCEMENT - "GEFITINIB TABLET" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-05-20 English
VOLUNTARY ANNOUNCEMENT - "AMBRISENTAN TABLET" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-05-09 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2019-05-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2019
Share Issue/Capital Change
2019-05-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2019
Share Issue/Capital Change
2019-05-03 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS
Report Publication Announcement
2019-04-29 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT THEREOF)
AGM Information
2019-04-29 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-29 English
GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2019-04-29 English
2018 ANNUAL REPORT
Annual Report FY 2018
2019-04-29 English
VOLUNTARY ANNOUNCEMENT - "FUDOSTEINE TABLETS" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2019-04-24 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-22 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
AGM Information
2019-04-22 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-22 English
Annual Report 2018
Annual Report FY 2018
2019-04-22 English
FACILITY AGREEMENT WITH SPECIFIC PERFORMANCE COVENANTS
Capital/Financing Update
2019-04-10 English
UPDATE ON THE SUPPLEMENTAL AGREEMENT TO THE LOAN AGREEMENT AND POSSIBLE CHANGE IN CONTROLLING SHAREHOLDER
Capital/Financing Update
2019-04-10 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2019
Share Issue/Capital Change
2019-04-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2019
Share Issue/Capital Change
2019-04-03 English
TERMS OF REFERENCE OF AUDIT COMMITTEE
Governance Information
2019-03-31 English
TERMS OF REFERENCE OF NOMINATION COMMITTEE
Governance Information
2019-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER, 2018
Annual Report FY 2018
2019-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2018
Annual Report FY 2018
2019-03-29 English
RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE
Board/Management Information
2019-03-29 English
INSIDE INFORMATION SUPPLEMENTAL AGREEMENT TO THE LOAN AGREEMENT AND POSSIBLE CHANGE IN CONTROLLING SHAREHOLDER
Capital/Financing Update
2019-03-28 English
POSITIVE PROFIT ALERT
Earnings Release FY 2018
2019-03-20 English
DATE OF BOARD MEETING
Report Publication Announcement
2019-03-19 English
TERMINATION OF MEMORANDUM OF UNDERSTANDING IN RESPECT OF A POSSIBLE ACQUISITION
M&A Activity
2019-03-15 English
TERMINATION OF PLACING OF NEW SHARES AND CONVERTIBLE BONDS
Capital/Financing Update
2019-03-13 English
PROFIT WARNING
Earnings Release FY 2018
2019-03-11 English
VOLUNTARY ANNOUNCEMENT "OLMESARTAN MEDOXOMIL TABLET" AND "ENTECAVIR CAPSULE" PASS CONSISTENCY EVALUATION
Regulatory Filings
2019-03-11 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2019
Share Issue/Capital Change
2019-03-04 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2019-02-28 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2019
Capital/Financing Update
2019-02-28 English
(1) PLACING OF NEW SHARES AND CONVERTIBLE BONDS UNDER SPECIFIC MANDATE (2) INSIDE INFORMATION IN RELATION TO MEMORANDUM OF UNDERSTANDING
Capital/Financing Update
2019-02-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2019
Capital/Financing Update
2019-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2019
Regulatory Filings
2019-02-01 English
INSIDE INFORMATION POSSIBLE ISSUANCE OF CONVERTIBLE BONDS WITH A PRINCIPAL AMOUNT OF UP TO HK$170 MILLION
Capital/Financing Update
2019-01-29 English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Board/Management Information
2019-01-29 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2019-01-18 English
VOLUNTARY ANNOUNCEMENT - LENALIDOMIDE CAPSULE OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-01-17 English
VOLUNTARY ANNOUNCEMENT - LINEZOLID AND GLUCOSE INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2019-01-09 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2019-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2018
Share Issue/Capital Change
2019-01-02 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2018
Regulatory Filings
2019-01-02 English